Orphazyme (private company)

See something wrong or missing? Let us know
Offices:
Copenhagen
Category:
Biotech
Business model:
B2B
Investors:
we tracked 4 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 2 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society.

Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.

Companies with similar profile to Orphazyme:

CompanyCriteria
Sweden OxThera
55%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Kurma Life Science Partners, Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Acarix
44%
  • Similar business models: B2B
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Flatfrog
44%
  • Similar business models: B2B
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Asarina Pharma
44%
  • Similar business models: B2B
  • At least one vc investor: Kurma Life Science Partners
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Blackwood Seven
44%
  • Similar business models: B2B
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Norway Oncoinvent
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark IO Biotech
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Norway BerGenBio
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Nuevolution
34%
  • Similar verticals: Biotech
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
Denmark Blast Premier
34%
  • Similar business models: B2B
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
Sweden Werlabs
33%
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Seriously
33%
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Optomed
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Tink
33%
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Scandinavian Real Hearts
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Finland BioMensio
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark Acesion Pharma
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Freespee
33%
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden BoneSupport
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Boozt Fashion
33%
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes